ipilimumab,nivolumab
bms,delcath systems
['chopin', '$dcth']
positive initial results from #chopin phase 1b trial, #focustrial update and qol study presented at #asco22 $dcth 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.